INSIGHTS ON CONTRACT PHARMA MANUFACTURING

• Enabling CTA Submission In Record Time: Adenovirus Program Success

  What does it take to bring an adenovirus-based therapy to the clinic – faster and without compromising quality? Find actionable insights to help improve efficiency and accelerate development timelines.

• What's Driving The Future Of Biopharma And Outsourcing Strategies?

  Review the rapidly evolving world of complex drug development and the critical factors that drive success for products made using different molecules beyond the traditional antibodies.

• Donor-To-Dose Solutions For Scalable Cell Therapy Manufacturing

  From enabling earlier insights through donor characterization to reducing manufacturing variability through cell separation technologies, explore real-world case studies and actionable approaches to scale smarter.

• The Fourth Principle Of Green Chemistry: Design Safer Chemicals

  Chemists should strive to design molecules with the least environmental impact. They can utilize toxicologists and data to apply new metrics and issue guidelines to better assess the safety of chemicals.

• From Design To Operation: Supporting GMP Facility Readiness

  Explore GMP facility readiness from design through operation, offering validation, quality systems, training, and ongoing compliance to ensure efficient, compliant, and future-ready pharmaceutical facilities.

• Quality By Design: How Laboratory Capabilities Enhance CDMO Partnerships

  Successful CDMO partnerships in sterile pharmaceutical manufacturing depend on advanced laboratory capabilities, transparent collaboration, and integrated systems that accelerate timelines, ensure compliance, and transform regulatory challenges into business advantages.

• Why Fill-Finish Strategy Can Make Or Break Your Drug Program

  Sterile injectable success depends on early CDMO partnerships. The right fill-finish partner ensures sterility, flexibility, regulatory compliance, and scalability, transforming development challenges into efficient, patient-centered commercial success.

• The Continuation Of A Journey

  One family managed to combine resources and people to get an investigational gene replacement therapy manufactured and approved by the FDA so their daughter could be dosed just 14 months from her diagnosis.

• The Team For Your Package Design Needs

  Our dedicated team of in-house design specialists deliver insightful packaging design and practical knowledge to deliver differentiated and cost-effective packaging solutions.

• Ensure The Safe And Efficient Development Of High Potent Drug Products

  As your product transitions from clinical phases to commercial launch, flexible, globally compliant facilities stand ready to adapt to your evolving needs.